Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

64.92
+0.61000.95%
Post-market: 65.000.0800+0.12%16:46 EDT
Volume:8.26M
Turnover:534.33M
Market Cap:288.18B
PE:19.08
High:65.33
Open:64.75
Low:64.12
Close:64.31
Loading ...

Novo Nordisk A/S Stock Rises Friday, Outperforms Market

Dow Jones
·
05 Jul

Are You Looking for a High-Growth Dividend Stock?

Zacks
·
04 Jul

US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy

Bloomberg
·
04 Jul

Will Novo Nordisk's Rare Disease Bets Reduce GLP-1 Reliance?

Zacks
·
04 Jul

Novo Nordisk Teams With WeightWatchers to Expand Wegovy Access

Insider Monkey
·
04 Jul

Lilly and Novo Are the Kings of Weight-Loss Drugs. The Companies Coming for Their Crowns. -- Barrons.com

Dow Jones
·
04 Jul

Novo Nordisk’s CagriSema Study: A Potential Game-Changer in Obesity Treatment

TIPRANKS
·
04 Jul

Septerna Announces Collaboration with Novo Nordisk

TIPRANKS
·
03 Jul

Novo Nordisk A/S Stock Rises Wednesday, Underperforms Market

Dow Jones
·
03 Jul

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

Motley Fool
·
02 Jul

Market Chatter: Novo Nordisk Executives Ignored Warnings Against Wegovy Launch

MT Newswires Live
·
01 Jul

Goldman Sachs Sticks to Their Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
01 Jul

Novo Nordisk A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
01 Jul

Novo Nordisk’s Bold Step in Tackling Childhood Obesity: A New Study Initiative

TIPRANKS
·
28 Jun

Novo Nordisk’s Promising Sickle Cell Study: A Potential Game-Changer?

TIPRANKS
·
28 Jun

Hims & Hers Stock Tumbles as Novo Nordisk Ends Its Wegovy Sales Deal. Can the Telehealth Giant Recover?

Motley Fool
·
27 Jun

Novo Nordisk A/S Stock Falls Thursday, Underperforms Market

Dow Jones
·
27 Jun

Novo Nordisk Stock (NVO) Inches Higher Despite More U.K. Weight Jab Concerns

TIPRANKS
·
26 Jun

Novo Nordisk announces WeightWatchers collaboration for Wegovy

TIPRANKS
·
26 Jun

Morgan Stanley Reaffirms Their Hold Rating on Novo Nordisk (0QIU)

TIPRANKS
·
26 Jun